UNIGE document Scientific Article
previous document  unige:44620  next document
add to browser collection
Title

Survival of European patients with central nervous system tumors

Authors
Sant, Milena
Minicozzi, Pamela
Lagorio, Susanna
Børge Johannesen, Tom
Marcos-Gragera, Rafael
Francisci, Silvia
CollaborationWith : Usel, Massimo
Published in International Journal of Cancer. 2012, vol. 131, no. 1, p. 173-85
Abstract We present estimates of population-based 5-year relative survival for adult Europeans diagnosed with central nervous system tumors, by morphology (14 categories based on cell lineage and malignancy grade), sex, age at diagnosis and region (UK and Ireland, Northern, Central, Eastern and Southern Europe) for the most recent period with available data (2000-2002). Sources were 39 EUROCARE cancer registries with continuous data from 1996 to 2002. Survival time trends (1988 to 2002) were estimated from 24 cancer registries with continuous data from 1988. Overall 5-year relative survival was 85.0% for benign, 19.9% for malignant tumors. Benign tumor survival ranged from 90.6% (Northern Europe) to 77.4% (UK and Ireland); for malignant tumors the range was 25.1% (Northern Europe) to 15.6% (UK and Ireland). Survival decreased with age at diagnosis and was slightly better for women (malignant tumors only). For glial tumors, survival varied from 83.5% (ependymoma and choroid plexus) to 2.7% (glioblastoma); and for non-glioma tumors from 96.5% (neurinoma) to 44.9% (primitive neuroectoderm tumor/medulloblastoma). Survival differences between regions narrowed after adjustment for morphology and age, and were mainly attributable to differences in morphology mix; however UK and Ireland and Eastern Europe patients still had 40% and 30% higher excess risk of death, respectively, than Northern Europe patients (reference). Survival for benign tumors increased from 69.3% (1988-1990) to 77.1% (2000-2002); but survival for malignant tumors did not improve indicating no useful advances in treatment over the 14-year study period, notwithstanding major improvement in the diagnosis and treatment of other solid cancers.
Keywords AdolescentAdultAge FactorsAgedAged, 80 and overCentral Nervous System Neoplasms/mortalityEuropeFemaleHumansMaleMiddle AgedRegistriesSex FactorsSurvival RateYoung Adult
Identifiers
PMID: 21805473
Full text
Article (Published version) (925 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Groupe Bouchardy Magnin Christine (Registre genevois des tumeurs) (532)
Citation
(ISO format)
SANT, Milena et al. Survival of European patients with central nervous system tumors. In: International Journal of Cancer, 2012, vol. 131, n° 1, p. 173-85. https://archive-ouverte.unige.ch/unige:44620

159 hits

0 download

Update

Deposited on : 2015-01-07

Export document
Format :
Citation style :